Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Head and Neck Carcinoma (CheckMate 141)

NCT02105636 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

361

Enrollment

INDUSTRY

Sponsor class

Conditions

Squamous Cell Carcinoma of the Head and Neck

Interventions

DRUG: Nivolumab
DRUG: Cetuximab
DRUG: Methotrexate
DRUG: Docetaxel

Sponsor

Bristol-Myers Squibb

Collaborators

[object Object]